Updates on UnitedHealth CEO Brian Thompson's killing

"We are shocked and heartbroken," Thompson's sister-in-law said. "We, like the rest of the world, found out online, which is shameful."

December 4, 2024 Check out STAT+

Sponsored By

UnitedHealth Group UnitedHealthcare CEO Brian Thompson became one of the country's most powerful insurance execs before tragic killing 'Shocked and heartbroken.' Reaction to the shooting death of Brian Thompson, highly respected CEO of one of America's largest health insurance companies. By Tara Bannow, Bob Herman, and Jonathan Wosen UnitedHealth exec Brian Thompson is killed in 'brazen, targeted' shooting UnitedHealth executives were in New York City on Wednesday for their annual investor conference, which was abruptly canceled. By Bob Herman, Tara Bannow, and Lev Facher STAT+ | Talks over big end-of-year health package heat up in Congress Republicans proposed paying for the policies with a full repeal of the Biden administration's controversial nursing home staffing rule By Rachel Cohrs Zhang Illustration: STAT; Source: Eli Lilly/AP STAT+ | Eli Lilly says its weight loss drug Zepbound outperformed Wegovy in a study Eli Lilly weight loss drug beat Wegovy in a head-to-head clinical trial — 20.2% body weight loss on Zepbound compared to 13.7% on Novo Nordisk obesity drug. By Matthew Herper 'Leptin's last chance': Mouse study says infamous weight loss drug failure could boost GLP-1s Mouse study published in Science Translational Medicine suggests an old approach to obesity, the leptin hormone, could improve efficacy of GLP-1 drugs. By Anil Oza STAT+ | Arrakis CEO cites 'cul-de-sacs' on road to RNA-intercepting cancer drugs Arrakis was formed with the idea of drugging RNA to fight cancer. Despite some promising data, CEO Michael Gilman is shifting targets. By Jason Mast ANDREW CABALLERO-REYNOLDS/AFP via Getty Images How the Supreme Court's transgender care case could reverberate across health care United States v. Skrmetti involves Tennessee's ban on gender-affirming care for minors, but politically charged case has wide ramifications for health care. By Theresa Gaffney

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser